Concept visual: Wild Bite Club. The cited IP filings do not confirm a product launch.
An active registration, a current US retail test and a newly granted process patent converge on a shake ingredient whose microbial protein is grown continuously from hydrogen, carbon dioxide and minerals.
| Filed mark | SOLEIN |
|---|---|
| Applicant | Solar Foods Oyj |
| Filing office | USPTO |
| Application | 79295136 |
| Filing date | 2020-08-25 |
| Nice classes | 5, 29, 32, 42 |
| Current status | LIVE/REGISTRATION/Issued and Active — Registered 2022-08-02 |
| Evidence level | FILING + MULTIPLE SIGNALS |
A directional signal: The filing supports a plausible category scenario, not a claim that the scenario will become a real product.
A Possible Category Future
If repeat purchase follows the current test, gas-fermented proteins could reach mainstream consumers first as components of blended powders rather than as visibly unfamiliar whole foods. That route would let formulators raise inclusion gradually, compare sensory performance against established isolates and preserve a recognizable preparation ritual. At larger scale, production could become less directly tied to arable acreage and seasonal crop yields, while facilities might be located around reliable low-carbon electricity and industrial gas handling. The category would then compete not only on grams of protein but on the controllability of its feedstock system. This scenario remains conditional. It depends on fermentation capacity, energy economics, regulatory clearance in each market, stable batch specifications and evidence that consumers accept both the ingredient story and the finished taste. A familiar shake can lower the trial barrier; it cannot by itself solve production cost or prove broad demand.
The Filing Behind the Signal
Solar Foods Oyj filed SOLEIN in the United States on August 25, 2020. USPTO TSDR now records serial 79295136 as an active registration issued on August 2, 2022, with Solar Foods Oyj as the current owner. Its four-class scope is unusually explicit. Class 5 covers protein supplements, powders, shakes and meal replacements; Class 29 covers prepared foods, dairy substitutes and meat substitutes; Class 32 covers protein-enriched beverages; and Class 42 covers food-technology research, testing and consultancy. The food and beverage wording repeatedly specifies products based on protein produced from air using electricity. That official language identifies a production platform, but the registration alone does not establish present sales, volume or market acceptance.
What Makes It Different
The mechanism begins with a microorganism rather than a field crop. US patent 12,600,940 B2, granted to Solar Foods Oyj on April 14, 2026, describes Xanthobacter strain VTT-E-193585, also identified as SoF1, and continuous culture processes for producing single-cell protein or biomass. In the disclosed system, hydrogen supplies energy, carbon dioxide supplies inorganic carbon, and oxygen plus mineral nutrients support growth. The resulting microbial biomass is harvested and processed into a protein-rich powder. “Made from air” is therefore shorthand, not the whole engineering story: electricity is used to enable the gas-based system, while controlled fermentation, nutrient dosing, gas transfer and downstream drying determine consistency and cost. In the current consumer product, Solein is blended with pea and brown-rice protein rather than carrying the formula alone. That matters because the commercial mechanism is a system: fermentation creates a new protein input; blending manages nutrition, flavor, texture and familiarity; powder format removes the need to solve chewing structure. Observable operator outcomes would include different feedstock exposure, new specification work around solubility and taste, and a formulation pathway that can introduce microbial protein without rebuilding the entire supplement format.
Why This Could Matter
Most protein powders rearrange familiar crop or dairy isolates. The current Solein experiment changes the source architecture while keeping the consumer ritual deliberately ordinary. Ambrosia Collective currently offers its Planta Solein Starter Kit as a ready-to-mix powder delivering 20 grams of protein from a blend of Solein, pea and brown-rice proteins, alongside vitamins and minerals. Protein Production Technology reported on June 4, 2026 that the salted-caramel cold-brew product was being test-marketed in the United States through Ambrosia and Amazon. For a consultant, that combination is more instructive than an exotic standalone ingredient: gas-fermented protein is entering through a scoop, shaker and performance claim consumers already understand. The transferable question is whether a novel production system can gain trial faster when it hides its novelty inside a familiar usage format and a blended protein system.
Evidence Still Missing
The next evidence should be operational and repeatable. Watch whether the Ambrosia product remains available beyond an initial campaign, receives repeat orders and expands into named retail or gym channels. Ingredient panels and future formulas should reveal whether Solein inclusion increases, stays a small supporting component or spreads into additional flavors and occasions. On the supply side, purchase orders, disclosed production volumes, factory utilization and additional third-party customers would show whether the platform is moving beyond a showcase batch. Regulatory signals also matter: Singapore’s food agency says foods containing Solein were approved for sale in 2022, but US and European expansion should be tracked through the relevant official assessment records rather than company statements alone. Finally, independent sensory testing, amino-acid data, digestibility results and finished-product price comparisons would clarify whether the gas-fermented input earns its place in the blend.
The WBC View
The strongest feature of this signal is alignment across different kinds of evidence. The active USPTO registration contains mechanism-specific wording; a current product page shows an actual consumer format; an independent trade report documents US test marketing; Singapore provides an official regulatory precedent; and the newly granted US patent explains the underlying organism and continuous-production logic. The main uncertainties are equally important. The trademark is not recent, the live product page is commercial material, the finished powder blends three protein sources, and none of the opened sources proves national retail scale or sustained repeat purchase. The filing should therefore be read as a durable intellectual-property marker that has become newly relevant because operating evidence has caught up with it. For consultants, this is a meaningful test of how an unfamiliar protein platform can be introduced through familiar behavior—not yet a verdict on whether gas fermentation will redraw the wider category.